Patents Assigned to NORDIC NANOVECTOR ASA
  • Method for upregulating antigen expression
    Patent number: 10646599
    Abstract: The present invention relates to radioimmunoconjugates that are capable of upregulating expression of one or more antigens. The upregulated antigens can be the antigens that are targeted by the radioimmunoconjugates or different antigens expressed on the same cells. The present invention also relates to methods of treating cancer and diseases and disorders of the immune system by utilizing this enhanced expression of antigens.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: May 12, 2020
    Assignee: NORDIC NANOVECTOR ASA
    Inventors: Roy H. Larsen, Ada Repetto-Llamazares